Business Of Fashion : Why So Many Fashion Brands Are for Sale Right Now

Why So Many Fashion Brands Are for Sale Right Now
Labels from Tom Ford and Ganni to Alyx and ALC are reportedly looking for new partners.

What do Tom Ford, Veronica Beard and 1017 Alyx 9SM have in common?

Not much, on the face of it. But these companies — an American luxury stalwart, contemporary market mainstay and streetwear-inspired designer label — are all considering sales, according to market sources. And they’re not the only ones.

Dozens of brands are said to have explored potential investments in recent months, from Los Angeles-based womenswear line ALC to Ganni, whose current owner — private equity firm L Catterton — is aiming to sell the Danish mid-priced sensation for up to $700 million, according to a recent Reuters report.

Other brands considering — or that have recently considered — sales or investments include Khaite, Canadian outerwear label Mackage and Oscar de la Renta, according to sources.

It’s easy to peg the influx to market conditions. After the early days of pandemic lockdowns, which slowed both production and sales, things picked up fast, and many brands are coming off their best year in business. But there are other reasons, too.

Many of the brands seeking a sale have private equity owners that invested four to six years ago and are ready to exit. That’s the case with Proenza Schouler, which is backed by the investment firm Mudrick Capital and went on the market earlier this year with sales projections of close to $57 million, according to a source. A deal did not materialise.

Matthew Williams-designed 1017 Alyx 9SM, which has long partnered with Luca Benini’s brand platform Slam Jam and generates less than $20 million a year in sales, according to sources, has considered an investment to help further capitalise on Williams’ celebrity connections — the label has been referenced in chart-topping Drake lyrics — high-profile Nike collaborations and creative director job with LVMH-owned Givenchy.

“The company is considering raising growth capital and has been approached by investors, as it has been self-funded up to this point,” a spokesperson told BoF. “It showed resilience through the pandemic.”

Isabel Marant’s private equity-backer Montefiore — a majority owner since 2016 — began shopping the label, which has excelled during the pandemic, earlier this year. Veronica Beard, known for stylish, American-mom friendly gear, is of a similar size and may be looking to expand further on that success with new owners.

Others are seeking a cash infusion for the first time. For instance, Australia-based Sir. The Label, which is mostly online and direct-to-consumer, is on track to double revenue by 2023, according to a market source, and is entertaining the option of raising money to open more stores and increase its digital marketing spend.

”There are a lot of young brands that have never had investors that have grown significantly during Covid,” said Gary Wassner, CEO of Hilldun, a fashion financier, who has also invested in companies like Mackage and ALC through his fund, InterLuxe. (He declined to comment on ALC or Mackage’s plans.) “Those brands are now thinking about their options — and retail takes capital investment.”

While some deals are expected to happen by the end of the year, buyers are becoming increasingly apprehensive.

“When there is concern about recession, people drop out of the consumer goods market,” Wassner said. “There are very few firms now competing.”

Strategic groups and private equity firms alike have backed down. Chinese investors, too, though quite active pre-pandemic, have receded as the country’s economy has suffered. While many brands continue to benefit from the post-pandemic bounce back, the strange economic situation — low unemployment, combined with high inflation and the energy shocks brought on by the war in Ukraine — means that many potential buyers are taking a wait-and-see approach.

“It’s a very selective market — too many small companies are thinking that they can sell too early,” said Elsa Berry, managing director and founder of Vendôme Global Partners. “People want proof of results.”

The deals that do go through are likely to involve bigger brands with solid growth potential — or are available at a significant discount. There are also special cases, such as Tom Ford’s mooted sale to Estée Lauder Companies, which already operates a large part of the Tom Ford business through its beauty licence.

“You can’t be a standard investor,” Wassner said. “You have to be creative. Brands today have to be really special and show real growth potential for them to be of interest.”

>>> US Research Calls

Research Calls

  • Upgrades:
    • AcuityAds Holdings (ATY) upgraded to Buy from Neutral at ROTH Capital; tgt $4
    • Boot Barn Holdings (BOOT) upgraded to Buy from Neutral at Seaport Research Partners; tgt $100
    • Cheniere Energy Partners (CQP) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $55
    • Expensify (EXFY) upgraded to Buy from Hold at Loop Capital
    • Fiserv (FISV) upgraded to Outperform from In-line at Evercore ISI
    • First Solar (FSLR) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $145
    • Healthcare Realty (HR) upgraded to Outperform from Neutral at SMBC Nikko; tgt $30
    • Shopify (SHOP) upgraded to Overweight from Neutral at Atlantic Equities; tgt $46
    • Walt Disney (DIS) upgraded to Buy from Neutral at Guggenheim; tgt raised to $145
  • Downgrades:
    • Atlas Corp (ATCO) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $14.45
    • BBQ Holdings (BBQ) downgraded to Hold from Buy at Craig Hallum
    • Barings BDC (BBDC) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $11.50
    • BuzzFeed (BZFD) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $2
    • Hyliion (HYLN) downgraded to Neutral from Overweight at Cantor Fitzgerald; tgt $5
    • Hyperfine (HYPR) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $2.40
    • Life Time (LTH) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $13
    • Lowe's (LOW) downgraded to Neutral from Buy at Citigroup; tgt lowered to $205
    • Marqeta (MQ) downgraded to Equal Weight from Overweight at Wells Fargo
    • Paysafe (PSFE) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $3
    • Paysafe (PSFE) downgraded to Underperform from Neutral at Credit Suisse; tgt lowered to $2
    • Professional Holding Corp (PFHD) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt raised to $35.50
    • Rackspace Technology (RXT) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $7
    • Red Robin Gourmet (RRGB) downgraded to Hold from Buy at The Benchmark Company
    • Seer (SEER) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $12
    • TelevisaUnivision (TV) downgraded to Neutral from Outperform at Credit Suisse; tgt $8
    • Traeger (COOK) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $4
    • Traeger (COOK) downgraded to Mkt Perform from Outperform at William Blair
    • Trinseo (TSE) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $34
    • Upstart (UPST) downgraded to Underweight from Neutral at Atlantic Equities; tgt lowered to $22
    • Welltower (WELL) downgraded to Neutral from Outperform at SMBC Nikko; tgt $84
    • XP (XP) downgraded to Neutral from Overweight at JP Morgan; tgt $23
  • Others:
    • Canadian Natrl Res (CNQ) assumed with a Neutral at Credit Suisse
    • Cenovus Energy (CVE) assumed with an Outperform at Credit Suisse
    • Chevron (CVX) assumed with an Outperform at Credit Suisse; tgt $202
    • Exxon Mobil (XOM) assumed with an Outperform at Credit Suisse; tgt $125
    • Imperial Oil (IMO) assumed with a Neutral at Credit Suisse
    • Oyster Point Pharma (OYST) initiated with a Buy at Chardan Capital Markets; tgt $22
    • Suncor Energy (SU) assumed with an Outperform at Credit Suisse
    • Tempur Sealy Int'l (TPX) initiated with a Buy at Goldman; tgt $34

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • SONO -17.4% (also CFO to step down, names new CFO), RRGB -14.2%, SIX -12.6%, COOK -11%, HBI -10.5%, BMBL -8.9%, APP -7.3%, PAAS -7%, HIMX -6.8%, AKA -6.3%, ENS -4.8%, MQ -3.8%, FSM -3.8%, AVT -3.7%, ACVA -2.6%, WKME -2%, CAH -1.9%, SWIM -1.3%, CLBT -1.2%, WRBY -0.8%

Other news:

  • ATNX -32.5% (prices $30 mln public offering of common stock and warrants)
  • CERE -9.7% (commences $250 mln stock offering)
  • SNY -9.2% (under pressure this morning amid concerns about litigation around recalled drug Zantac)
  • GSK -8.5% (under pressure this morning amid concerns about litigation around recalled drug Zantac)
  • BNL -5.7% (prices offering of 13.0 mln shares of common stock at $21.35 per share)
  • MAIN -5.3% (commences $50 mln stock offering)
  • LXU -3.1% (prices offering of 13.5 mln shares of common stock at $13.00 per share by selling shareholders)
  • LNDC -2.9% (rebrands as Lifecore Biomedical names new CEO)
  • KRG -2.8% (increases dividend)
  • KIDS -2.6% (stock offering)
  • HLN -2.6% (under pressure this morning amid concerns about litigation around recalled drug Zantac)
  • CINC -1.6% (prices offering of common stock and pre-funded warrants)
  • ZEV -1.3% (files $250 mln mixed securities shelf offering)
  • VRNA -1.3% (prices offering of $12.4 mln shares of common stock at $10.50 per share)
  • DCPH -1% (announces publication of INTRIGUE Phase 3 study of QINLOCK)

Analyst comments:

  • PSFE -3.2% (downgraded to Sector Perform from Outperform at RBC Capital Mkt; downgraded to Underperform from Neutral at Credit Suisse)
  • LOW -1.8% (downgraded to Neutral from Buy at Citigroup)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • VCSA +24.3%, MTTR +19.7%, ENVX +19.1%, DDS +18.7%, VZIO +11.1%, NOTV +11%, ACHR +8.7%, DIS +8.6% (also will launch ad-supported tier for Disney+ on Dec. 8; also ups prices for no-ads options), STKL +8.2%, UTZ +8.2%, PRVA +7.9%, PRMW +7.1%, DCBO +6.5%, BROS +6.2%, DTC +6.1%, KELYA +5.6%, CPNG +5.3%, GLNG +4.1%, EQRX +3.5%, STAA +3.3%, AOSL +3.3%, DHT +2.8%, AIT +2.8%, SGHC +2.3%, AER +2.2%, FNV +1.7%, GOOS +1.5%

Other news:

  • LHDX +5% (announced that Health Canada has granted Authorization under Interim Order for the emergency use and commercialization of the first and only at-home test for COVID & Flu)
  • COIN +3.1% (being investigated over staking programs according to Bloomberg)
  • JHX +2.6% (provides Chairperson succession plan)
  • ARGX +2% (EC grants marketing authorization for VYVGART)
  • DNA +1.9% (Synlogic (SYBX) announced a new drug candidate for the treatment of gout developed in partnership with Ginkgo Bioworks)
  • EVGO +1.8% (files for $750 mln mixed securities shelf offering; also stock offering)
  • VCTR +1.5% (reports July AUM)
  • NTRA +1.3% (files pre-submission to FDA for its Panorama non-invasive prenatal test)
  • NL +1.1% (special dividend of $0.35/sh)
  • ECOM +1.1% (announces integration with Shopee)

Analyst comments:

  • FSLR +2.6% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
  • ATY +2.3% (upgraded to Buy from Neutral at ROTH Capital)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • VCSA +22.4%, ENVX +21.1%, MTTR +14.1%, NOTV +11.9%, VZIO +11.1%, ACHR +8.7%, DIS +8.3%, CPNG +6.7%, AOSL +5.8%, GLNG +5.6%, STKL +3%, GPRK +2.9%, BROS +2.8%, COIN +2.7%, JHX +2.6%, DHT +1.9%, FNV +1.7%, BHC +1.6%, VCTR +1.5%, NL +1.1%, ECOM +1.1%, VRNA +1%
  • Gapping down:
    • ATNX -31.5%, SONO -20.1%, RRGB -18.3%, COOK -14%, CERE -9.5%, SIX -8.8%, APP -7.7%, BMBL -7.2%, AKA -6.3%, BNL -6.2%, MQ -5.4%, PAAS -5.4%, ENS -4.8%, MAIN -4.5%, AVT -3.7%, AXON -3.2%, LNDC -2.9%, KRG -2.8%, FSM -2.7%, KIDS -2.6%, LXU -2.5%, CACI -2.3%, DCPH -1%

>>> Europe : Brokers Upgrades & Downgrades - 11th of August 2022

>>> Up
* E.On Raised to Buy at DZ Bank; PT 10.80 euros (+)
* Komax Raised to Add at Baader Helvea; PT 300 Swiss francs
* Vestas Raised to Buy at DZ Bank; PT 225 kroner (+)

>>> Down
* Chrysalis Investments Cut to Hold at Stifel (+)
* Covestro Cut to Neutral at Oddo BHF; PT 39 euros
* Deliveroo Cut to Neutral at Citi; PT 110 pence
* Intl Petroleum Cut to Equal-Weight at Barclays; PT 148 kronor
* Jupiter Cut to Sell at Canaccord; PT 114 pence (+)
* MaaT Pharma Cut to Accumulate at KBC Securities; PT 11 euros
* Scatec Cut to Hold at Norne Securities; PT 125 kroner (+)
* TAG Immobilien Cut to Sell at Deutsche Bank; PT 9.50 euros

>>> Initiation
* Generalfinance Rated New Buy at Intesa Sanpaolo; PT 10.20 euros (+)
* Harbour Energy Reinstated Buy at Goldman; PT 609 pence

>>> Call
* Aegon 2Q a Strong Beat Across a Number of Key Lines: Citi (+)
* Ceconomy Is Coming Against ‘Perfect Storm,’ Baader Helvea Says (+)
* Deliveroo Cut to Neutral at Citi on Limited Upside Potential
* Deutsche Telekom 2Q Strong With Germany, FCF Solid: Citi (+)
* KBC’s Improved Guidance Should Drive Upgrades: Morgan Stanley (+)
* Komax Upgraded to Add at Baader After Schleuniger Deal
* Metro 3Q an Ebitda Beat, Lacks Details on Key Issues: Jefferies
* Orsted Revenue Beat, Upped Guidance Welcome: RBC Capital Markets (+)
* Spirax 1H Results Solid, Outlook ‘Encouraging’: Morgan Stanley (+)
* Westwing’s Lowered Guidance in Line With Expectations: Jefferies (+)
* Zurich Insurance Results ‘Very Strong,’ Buyback Positive: MS

>>> Stoxx 600 Pre-Market Indications

  • K+S (SDF TH) +4%
    • K+S Maintains FY Ebitda Forecast, Misses Estimates
  • Thyssenkrupp (TKA TH) +3%
    • Thyssenkrupp Lowers Profit Outlook Amid Rising Rates (Correct)
  • GSK (GS71 TH) +2.6%
    • Sanofi Zantac Risk Overdone, Haleon Exposure Limited: Analysts
  • Aegon (AEND TH) +2.5%
    • Aegon 2Q Net Loss EU365M Vs. Profit EU842M Y/y
  • Sanofi (SNW TH) +1.5%
    • Sanofi Zantac Risk Overdone, Haleon Exposure Limited: Analysts
  • Orsted (D2G TH) +1.3%
    • Orsted FY Ebitda Forecast Misses Estimates
  • Wacker Chemie (WCH TH) +1.1%
  • ASML (ASME TH) +1%
  • SocGen (SGE TH) -0.6%
  • Shell (R6C0 TH) -0.6%
    • Kazakhstan Raises Daily Output by 4% as Kashagan Resumes Output
  • M&G (7MP TH) -0.8%
    • M&G 1H Adjusted Operating Profit Beats Estimates
  • ProSieben (PSM TH) -0.9%
    • ProSieben Cuts FY Revenue Forecast, Misses Estimates
  • Vestas (VWSB TH) -1%
  • Nibe (NJB TH) -1%
  • Tomra (TMRA TH) -1%
  • Aroundtown (AT1 TH) -1.2%
  • Siemens (SIE TH) -2.2%
    • Siemens Cuts FY EPS Before Purchase Price Allocation Forecast
  • TAG Immobilien (TEG TH) -3.8%
    • TAG Immobilien Cut to Sell at Deutsche Bank; PT 9.50 euros

>>> TradeGate Pre-Market Indications

DAX:
  • Daimler Truck (DTG TH) +1.3%
    • Daimler Truck Shrugs Off Supply-Chain Issues With Rising Sales
  • RWE (RWE TH) +1.2%
    • RWE Ups Spending on ‘Independent’ Supplies as Gas Crisis Deepens
  • Infineon (IFX TH) +0.9%
  • Fresenius SE (FRE TH) +0.9%
  • Qiagen (QIA TH) +0.8%
  • Covestro (1COV TH) -0.5%
    • Covestro Cut to Neutral at Oddo BHF; PT 39 euros
  • Siemens (SIE TH) -2%
    • Siemens Cuts FY EPS Before Purchase Price Allocation Forecast
MDAX:
  • K+S (SDF TH) +4.6%
    • K+S Maintains FY Ebitda Forecast, Misses Estimates
  • Thyssenkrupp (TKA TH) +3.6%
    • Thyssenkrupp Lowers Profit Outlook Amid Rising Rates
  • Cancom (COK TH) +2.2%
  • Sixt (SIX2 TH) +1.8%
  • Siltronic (WAF TH) +1.7%
  • Rheinmetall (RHM TH) +0.4%
  • Encavis (ECV TH) -0.4%
  • TAG Immobilien (TEG TH) -2.7%
    • TAG Immobilien Cut to Sell at Deutsche Bank; PT 9.50 euros
SDAX:
  • Salzgitter (SZG TH) +2.5%
    • Salzgitter 2Q Pretax Profit Beats Estimates
  • Heidelberger Druck (HDD TH) +2.4%
  • Jenoptik (JEN TH) +1.4%
  • Ceconomy (CEC TH) +1.3%
    • Ceconomy 3Q Adjusted Ebit Loss EU109M Vs. Loss EU93M Y/y
  • Deutz (DEZ TH) +1.1%
    • Deutz 2Q Adjusted Ebit EU26.8M
  • Adler Group (ADJ TH) +0.1%
    • Adler Gets ~EU166m From Sale of Two Frankfurt Projects
  • AUTO1 (AG1 TH) -0.1%
  • About You (YOU TH) -0.2%
  • PVA TePla (TPE TH) -0.7%
  • SMA Solar (S92 TH) -2.3%
    • SMA Solar 1H Ebitda EU16.0M Vs. EU38M Y/y

FT : Active funds can beat passive if fees are low enough, study shows

Active funds can beat passive if fees are low enough, study shows
Retail investors miss out on outperformance enjoyed by institutional investors due to higher costs

Retail investors are missing out on active funds’ outperformance of passives because they pay higher fees than institutional investors, new research shows.

Different fee levels mean fund share classes that are accessible to institutional investors have outperformed passives, but retail investors’ share classes have underperformed, a group of four Dutch researchers has found.

The research paper, Fund Selection: Sense and Sensibility, is the result of analysis of the performance of Luxembourg and Ireland-based Ucits equity and fixed-income funds between 2008 and 2020.

Actively managed funds’ performance, both gross and net of costs, was compared with passive funds and index benchmarks, with results weighted by funds’ assets to reflect where most client money was held.


This article was previously published by Ignites Europe, a title owned by the FT Group.

Active equity funds on average outperformed passive funds by 0.56 per cent a year before the impact of costs was included.

Looking at 35 separate equity fund categories — such as global emerging markets and UK large caps — the researchers found that active funds outperformed in 28 categories, or 80 per cent, although this outperformance was only deemed to be statistically significant for six of them.

This outperformance “weakened” when the impact of funds’ fees was included in the analysis.

Evidence of outperformance was “still there” for 25, or 71 per cent, of the fund categories when looking at institutional share classes after accounting for fund fees.

But this evidence is only present for 16, or 46 per cent, of fund categories when retail share classes are examined.

“Active equity managers can outperform the passive alternative when fees are reasonable,” the authors concluded.

The research is “less supportive” for active fixed-income managers, the researchers said.

“Retail investors experienced negative net outperformance due to the level of fees across fixed-income categories.”

But even for fixed income, lower fees meant institutional investors experienced positive net outperformance in three of the seven fund categories assessed.

The researchers also presented active funds’ outperformance of passives in absolute terms. By combining percentage returns with funds’ total net assets, the researchers found the average “value added” by active funds each year.

Using this approach, active equity funds on average were found to add value of €220,000 a year before fees for retail investors.

“Unfortunately, the retail investor — given the fees — could not benefit much from this active management skill since the average €410,000 in fees charged largely exceed the gross value added,” the researchers write.

As a result, average active equity funds ended up losing value for their retail clients of €190,000 a year.

This finding was not consistent across all fund categories, however, with average active funds in 15 categories, 43 per cent of the total, able to deliver positive value to retail investors after fees.

Retail share classes’ ongoing charges averaged 1.71 per cent, while institutional classes averaged 0.82 per cent across all active equity funds analysed, the research shows.

Equivalent charges for fixed-income funds averaged 1.13 per cent for retail clients and 0.47 per cent for institutions.

Ucits funds’ retail share classes are distributed across widely different geographies, most of which still allow for the payment of retrocessions, which increase the funds’ annual charges, the researchers added.

“As the ban on retrocessions becomes more widespread, we would expect [ . . .] retail fees to decrease to reflect this change,” Jan Jaap Hazenberg, one of the report’s authors, told Ignites Europe.

“They could/should eventually converge to the institutional level,” he said.

FT : The Greek brand making mythology look modern

The Greek brand making mythology look modern
The founders of Ancient Greek Sandals on building an international fan base with their heritage-inspired footwear

In 2008, Christina Martini and Nikolas Minoglou were introduced by a mutual friend and went out for dinner together in Athens. Their subject for discussion? Greek sandals. Martini, who trained at Cordwainers in London, was at that time living in Paris, a high-flying shoe designer at Balenciaga who had previously worked with Marc Jacobs at Louis Vuitton. Minoglou, whose grandfather founded a rubber shoe business in Greece in the 1950s, had recently completed an MBE at Babson College in Boston and was looking to set up something of his own.

“We had both realised there was a hole in the market,” says Martini, speaking from her studio in Corfu, where she now lives with her husband Apostolos Porsanidis Kavvadias and young family on an olive farm. “We wanted to make Greek touristic sandals in good quality and export them.”

“Our friends would come to Greece and they would buy sandals and olive oil and go back home,” adds Minoglou. “We knew people liked them. But we realised that the quality and design were not where they should be. We saw Greeks looking down on the sandals, on the heritage. We wanted to do the opposite, take our heritage and make it into something more modern and better. It was a very specific idea, hence the name.”

This year, Ancient Greek Sandals is celebrating a decade in the business. Manufacturing in Greece and selling across the world, from America to Japan, via its own website (ancientgreeksandals.com) and Athens flagship, and through retailers such as Le Bon Marché and Net-a-Porter, it has a loyal following across its ranges for men, women and children. Designs range from the traditional leather thin-soled strappy Greek sandal to trendier contemporary versions studded with crystals or in coloured rubbers. The brand also produces sandals with thicker soles for urban environments, as well as clogs and flip flops. The simpler leather styles for women start at about £155 — which is twice the price of the most basic Birkenstock, but only a quarter that of equivalent styles from international designer names — and clogs can go up to £295.

Different regions favour different varieties. From the beginning, Ancient Greek Sandals’ biggest market has been America. “They prefer the more bling styles, the evening styles, the crystals that we’ve done lately. Or jewels from our collaboration with [the New York fine jewellery brand] Lalaounis,” says Martini. “Americans also like something soft. That’s one of the reasons we did a comfort construction, with a thicker sole. The Asian market likes that too. The French really admire ancient Greek culture, so they prefer the leather styles that have straps and cut-outs. But everyone in the world is familiar with Greek mythology, with ancient Greek art and architecture, so it’s an easy concept to love.”

The brand’s anniversary capsule collection celebrates that perennial fascination with the land of the gods, with 10 sandal designs inspired by ancient Greek sculpture. Martini worked with art historian Xenia Ventikou to select pieces currently found in international museums, including the Louvre, the British Museum and the Metropolitan Museum of Art.

“I had in mind to tell the tale of women, goddesses, priestesses, matriarchs and heroines, each one unique in her own way,” says Ventikou. “We also wanted to cover the whole length of Greek art, from the Geometric period to the Romans.” Martini and the design team honed in on seven statues, two figurines and one vase, finding details and motifs within them for design inspiration: twisted necklaces seen on ancient clay figures; the delicately pleated robes of classical statuary; the ankle-tied sandals found in sculptures of Artemis the hunter; and the wings of the Winged Victory of Samothrace and draped skirts of the Venus de Milo, two of the most famous statues in the world, both found today in the Louvre. “I just love the way that the famous hair-locks of the Dame d’Auxerre were turned into a lace, and the arm bracelet of the Crouching Venus became ankle jewellery,” says Ventikou.

In the still shaky days following the Greek financial crisis, building Ancient Greek Sandals as an international but seasonal brand, outside of the traditional fashion capitals, was always going to be a challenge. Only a handful of Greek fashion brands, such as Zeus & Dione, have made global names for themselves from their home country. Marios Schwab and the late Sophia Kokosalaki both found success in London. “Yes, things can be more difficult in Greece compared to starting up something in a fashion capital,” says Minoglou, “but on the other hand, because Athens is a smaller community, and because we had my grandfather’s and father’s business as a platform, we had lots of contacts with factories and administration. The crisis was in fact helpful because in the four years afterwards, factories were still closing down and those open had excess capacity. We were able to get their attention more easily.”

Seasonality was factored in from the beginning. “We both agreed it was better to focus and do something really well than have a multi-season, multi-category brand,” says Minoglou. “Sales aren’t as strong during winter,” adds Martini. “We have the southern hemisphere, Australia, but there’s no comparison to the European/American summer season.”

According to Minoglou, the company has been profitable, without loans, since year one. “Since 2017 to now, the brand has grown 25 per cent on wholesale and direct to consumer,” he says. “Covid brought us down 30 per cent overall, but now we’re at pre-pandemic levels, slightly more.” The pandemic hit the company with problems in wholesale and the dramatic hiatus in international travel. It halted production for three months. “We adopted a more aggressive strategy in terms of digital marketing because our online shop was up and running throughout. So we did promoted posts to liquidate stock and introduced an upcycled collection very fast that had a lower starting price. We came out of it healthy, with no major scars.”

The brand, which opened its flagship boutique in Athens in 2019, has recently expanded to homeware, including blankets and leather basketry inspired by Martini and Kavvadias’s home on the olive farm, and introduced a collection of leather bags (starting at £155) and crochet bags (starting at £215), which Martini and Minoglu expect to be a significant future category. Collaborations with other brands and individuals continue to be a way of introducing creative newness into the tried-and-tested sandals. There have already been partnerships with the Australian jeweller Lucy Folk, influencer Harley Viera Newton and the Hotel Sirenuse on the Amalfi coast. Future plans include setting up a store within an international hotel.

While Minoglou is based at the offices in Athens, close to manufacturers and suppliers, Martini continues to finds inspiration in her sea-view location in Corfu, where she moved from Paris the same year they established the brand. “If it hadn’t worked out with the sandals, I’d have to have moved back again,” she says. A decade in and that is not a concern. “For designing high fashion, I don’t think Corfu would work, but for what I do now it’s the perfect place to be.”